239 related articles for article (PubMed ID: 7070726)
21. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. I. Adenocarcinoma in situ.
Ayer B; Pacey F; Greenberg M; Bousfield L
Acta Cytol; 1987; 31(4):397-411. PubMed ID: 3604534
[TBL] [Abstract][Full Text] [Related]
22. Glandular lesions of the uterine cervix.
Zaino RJ
Mod Pathol; 2000 Mar; 13(3):261-74. PubMed ID: 10757337
[TBL] [Abstract][Full Text] [Related]
23. Comparative cytologic features of adenocarcinoma in situ of the uterine cervix.
Lee KR; Manna EA; Jones MA
Acta Cytol; 1991; 35(1):117-26. PubMed ID: 1994620
[TBL] [Abstract][Full Text] [Related]
24. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
25. [Characteristics of uterine cancer detected by mass screening].
Igarashi T; Konno R; Sato S; Yajima A
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1519-26. PubMed ID: 9725043
[TBL] [Abstract][Full Text] [Related]
26. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
27. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group.
La Ruche G; Ramon R; Mensah-Ado I; Bergeron C; Diomandé M; Sylla-Koko F; Ehouman A; Touré-Coulibaly K; Welffens-Ekra C; Dabis F
Cancer; 1998 Jun; 82(12):2401-8. PubMed ID: 9635533
[TBL] [Abstract][Full Text] [Related]
28. Cytologic screening for cervical cancer in southern Iran.
Behmard S; Taherzadeh D; Gondos B
Acta Cytol; 1977; 21(3):432-4. PubMed ID: 268125
[TBL] [Abstract][Full Text] [Related]
29. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
30. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
32. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of cervical carcinoma in Brunei Darussalam. Analysis of data on 27,208 women screened with cytologic examinations.
Affandi MZ; Dun T; Mantuano V; Sidhu R; Lumplugh C; Telisinghe PU
Acta Cytol; 1993; 37(2):175-80. PubMed ID: 8465637
[TBL] [Abstract][Full Text] [Related]
34. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
Smith HO; Tiffany MF; Qualls CR; Key CR
Gynecol Oncol; 2000 Aug; 78(2):97-105. PubMed ID: 10926787
[TBL] [Abstract][Full Text] [Related]
35. Mass cytologic screening for cervical carcinoma in China. A review of 7,735,057 reported cases.
Yang DW; Yao JF; Xing SF; Lin YX
Acta Cytol; 1985; 29(3):341-4. PubMed ID: 3859133
[TBL] [Abstract][Full Text] [Related]
36. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
37. [Gynecology-obstetrics at the Yalgado-Ouédraogo (Ouagadougou) National Hospital Center. Cancer of the cervix uteri: epidemio-clinical and anatomopathologic aspects].
Lankoandé J; Sakandé B; Ouédraogo A; Ouédraogo CM; Ouattara T; Bonané B; Koné B
Sante; 1997; 7(4):227-30. PubMed ID: 9410446
[TBL] [Abstract][Full Text] [Related]
38. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
[TBL] [Abstract][Full Text] [Related]
39. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
Nieminen P; Kallio M; Hakama M
Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
[TBL] [Abstract][Full Text] [Related]
40. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins.
Wolf JK; Levenback C; Malpica A; Morris M; Burke T; Mitchell MF
Obstet Gynecol; 1996 Jul; 88(1):82-6. PubMed ID: 8684768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
